[ad_1]
Linmon Media, which listed on 10 August 2022, produces and distributes Chinese television drama series, and provides content marketing, derivative licensing and overseas distribution services.
“We are delighted to have worked with Linmon Media, one of the leading entertainment studios in China, on its listing on the Hong Kong Stock Exchange,” said Hong Kong partner Matt Emsley. “We congratulate the company and sponsors on this successful IPO.”
“We have a strong track record of advising on cross-border transactions for Chinese companies seeking access to international investors,” said Beijing partner Zhong Wang. ”In fact, this is the second high-profile Chinese listing in Hong Kong that we have acted on in the last month.”
“Our team, located across offices in Hong Kong and Mainland China, collaborated closely to provide quality legal services to our clients,” said Hong Kong senior registered foreign lawyer Jin Kong. “We look forward to continuing to work with our clients and wish Linmon Media every success post listing.”
Partners Matt, Zhong and Jin jointly led the team advising the sponsors, supported by senior associate Jaime Fong, associates Angela Yuen, Eric Yeung, Samuel Au, Brian Ge and Kathy Zhang, trainee Colbert Hung, legal assistants Phyllis Liang and Emma Chen. Associates Kaiwen Sun and Alison Pan provided assistance.
Legal manager Marine Jin led Herbert Smith Freehills Kewei Joint Operation’s Alternative Legal Services business to provide high-efficiency solutions for verification and other document-intensive processes during the listing, assisted by senior legal analysts Shawna Peng and Jean Zhou, and legal specialist Jiang Ling.
Herbert Smith Freehills has significant expertise advising Chinese companies on capital markets transactions. Recently the firm advised Huatai Financial Holdings as the sole sponsor of medical device company Rainmed Medical Limited (02297.HK)’s mainboard listing on the Hong Kong Stock Exchange.
[ad_2]
Source link
